MXPA97002768A - New effective and high selectivity procedureanantiomerica for the production of ciclopentano-beta- aminoacidos enantiomericamente pu - Google Patents
New effective and high selectivity procedureanantiomerica for the production of ciclopentano-beta- aminoacidos enantiomericamente puInfo
- Publication number
- MXPA97002768A MXPA97002768A MXPA/A/1997/002768A MX9702768A MXPA97002768A MX PA97002768 A MXPA97002768 A MX PA97002768A MX 9702768 A MX9702768 A MX 9702768A MX PA97002768 A MXPA97002768 A MX PA97002768A
- Authority
- MX
- Mexico
- Prior art keywords
- general formula
- enantiomerically pure
- compounds
- process according
- cyclopentane
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 29
- 150000002148 esters Chemical group 0.000 claims abstract description 14
- 150000001540 azides Chemical class 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 230000000875 corresponding Effects 0.000 claims abstract description 12
- 238000010494 dissociation reaction Methods 0.000 claims abstract description 11
- 230000005593 dissociations Effects 0.000 claims abstract description 11
- 239000012442 inert solvent Substances 0.000 claims abstract description 11
- 150000008064 anhydrides Chemical class 0.000 claims abstract description 10
- 150000002513 isocyanates Chemical class 0.000 claims abstract description 10
- JOYRKODLDBILNP-UHFFFAOYSA-N ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 150000004808 allyl alcohols Chemical class 0.000 claims abstract description 7
- 238000006136 alcoholysis reaction Methods 0.000 claims abstract description 5
- 239000011780 sodium chloride Substances 0.000 claims abstract description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 claims abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 32
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- 125000004432 carbon atoms Chemical group C* 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 238000006969 Curtius rearrangement reaction Methods 0.000 claims description 13
- 239000001257 hydrogen Substances 0.000 claims description 12
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 11
- -1 substituents halogen Chemical class 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 125000005842 heteroatoms Chemical group 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 230000000269 nucleophilic Effects 0.000 claims description 3
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 3
- 229910052717 sulfur Inorganic materials 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000005256 alkoxyacyl group Chemical group 0.000 claims description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000005254 oxyacyl group Chemical group 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N Triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 10
- IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000002585 base Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 150000002431 hydrogen Chemical class 0.000 description 6
- 239000003480 eluent Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 229940113083 morpholine Drugs 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000002194 synthesizing Effects 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- YJVFFLUZDVXJQI-UHFFFAOYSA-L Palladium(II) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 3
- 229910002666 PdCl2 Inorganic materials 0.000 description 3
- LOUPRKONTZGTKE-LHHVKLHASA-N Quinidine Natural products C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 229930013930 alkaloids Natural products 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N o-xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 230000001131 transforming Effects 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- CYPYTURSJDMMMP-WVCUSYJESA-N (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 CYPYTURSJDMMMP-WVCUSYJESA-N 0.000 description 2
- WRJRZNHDCDDIFH-OLQVQODUSA-N (1S,2R)-4-methylidenecyclopentane-1,2-dicarboxylic acid Chemical compound OC(=O)[C@H]1CC(=C)C[C@H]1C(O)=O WRJRZNHDCDDIFH-OLQVQODUSA-N 0.000 description 2
- LOUPRKONTZGTKE-AFHBHXEDSA-N (R)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol Chemical compound C([C@H]([C@H](C1)C=C)C2)CN1[C@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-AFHBHXEDSA-N 0.000 description 2
- NHSVULNBUWARIO-UHFFFAOYSA-N 2,2-diethoxyethyl diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(OCC(OCC)OCC)OC1=CC=CC=C1 NHSVULNBUWARIO-UHFFFAOYSA-N 0.000 description 2
- 229960000583 Acetic Acid Drugs 0.000 description 2
- 241000157855 Cinchona Species 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- 241000434299 Cinchona officinalis Species 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N MeOtBu Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- 101710027499 Os03g0268000 Proteins 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N Phosphoryl chloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229960000948 Quinine Drugs 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000005712 crystallization Effects 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 2
- SJRJJKPEHAURKC-UHFFFAOYSA-N n-methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 2
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 229960001404 quinidine Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- JWYOAMOZLZXDER-UHNVWZDZSA-N (1R,2S)-2-azaniumylcyclopentane-1-carboxylate Chemical compound N[C@H]1CCC[C@H]1C(O)=O JWYOAMOZLZXDER-UHNVWZDZSA-N 0.000 description 1
- ASJCSAKCMTWGAH-SYDPRGILSA-N (1R,2S)-cyclopentane-1,2-dicarboxylic acid Chemical compound OC(=O)[C@H]1CCC[C@H]1C(O)=O ASJCSAKCMTWGAH-SYDPRGILSA-N 0.000 description 1
- KMPWYEUPVWOPIM-SPLQCWDRSA-N (R)-[(2S,4S,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-quinolin-4-ylmethanol Chemical compound C1=CC=C2C([C@H]([C@H]3N4CC[C@H]([C@@H](C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-SPLQCWDRSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- MVZVDAGWAAZJPE-UHFFFAOYSA-N 1,2-xylene;1,3-xylene;1,4-xylene Chemical compound CC1=CC=C(C)C=C1.CC1=CC=CC(C)=C1.CC1=CC=CC=C1C MVZVDAGWAAZJPE-UHFFFAOYSA-N 0.000 description 1
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 description 1
- AFBBKYQYNPNMAT-UHFFFAOYSA-N 1H-1,2,4-triazol-1-ium-3-thiolate Chemical compound SC=1N=CNN=1 AFBBKYQYNPNMAT-UHFFFAOYSA-N 0.000 description 1
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Chemical compound CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-Methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- QVEMWYGBLHQEAK-UHFFFAOYSA-N 2-ethylbutanamide Chemical compound CCC(CC)C(N)=O QVEMWYGBLHQEAK-UHFFFAOYSA-N 0.000 description 1
- LRDFRRGEGBBSRN-UHFFFAOYSA-N 2-methylpropanenitrile Chemical compound CC(C)C#N LRDFRRGEGBBSRN-UHFFFAOYSA-N 0.000 description 1
- NMSRALOLNIBERV-UHFFFAOYSA-N 4,5,6,6a-tetrahydro-3aH-cyclopenta[c]furan-1,3-dione Chemical compound C1CCC2C(=O)OC(=O)C21 NMSRALOLNIBERV-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- WRJRZNHDCDDIFH-UHFFFAOYSA-N 4-methylidenecyclopentane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CC(=C)CC1C(O)=O WRJRZNHDCDDIFH-UHFFFAOYSA-N 0.000 description 1
- VPCZJTZBDBBKCG-UHFFFAOYSA-N 5-methylidene-3a,4,6,6a-tetrahydrocyclopenta[c]furan-1,3-dione Chemical compound O=C1OC(=O)C2C1CC(=C)C2 VPCZJTZBDBBKCG-UHFFFAOYSA-N 0.000 description 1
- XXROGKLTLUQVRX-UHFFFAOYSA-N Allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 1
- VZTDIZULWFCMLS-UHFFFAOYSA-N Ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 1
- JFDZBHWFFUWGJE-UHFFFAOYSA-N Benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 1
- OOCCDEMITAIZTP-QPJJXVBHSA-N Cinnamyl alcohol Chemical compound OC\C=C\C1=CC=CC=C1 OOCCDEMITAIZTP-QPJJXVBHSA-N 0.000 description 1
- BADXJIPKFRBFOT-UHFFFAOYSA-N Dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 1
- 238000007167 Hofmann rearrangement reaction Methods 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N N-Butylamine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- KAHVZNKZQFSBFW-UHFFFAOYSA-N N-methyl-N-trimethylsilylmethanamine Chemical compound CN(C)[Si](C)(C)C KAHVZNKZQFSBFW-UHFFFAOYSA-N 0.000 description 1
- MDGFHNSVMXUJRE-UHFFFAOYSA-M NC1(CCC(C1)=C)C(=O)[O-] Chemical compound NC1(CCC(C1)=C)C(=O)[O-] MDGFHNSVMXUJRE-UHFFFAOYSA-M 0.000 description 1
- RKOUGZGFAYMUIO-RITPCOANSA-N PDL 118 Chemical compound N[C@H]1CC(=C)C[C@H]1C(O)=O RKOUGZGFAYMUIO-RITPCOANSA-N 0.000 description 1
- 101710015476 PPP4C Proteins 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N Phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- DBGVGMSCBYYSLD-UHFFFAOYSA-N Tributyltin hydride Chemical compound CCCC[SnH](CCCC)CCCC DBGVGMSCBYYSLD-UHFFFAOYSA-N 0.000 description 1
- IGNTWNVBGLNYDV-UHFFFAOYSA-N Triisopropylphosphine Chemical compound CC(C)P(C(C)C)C(C)C IGNTWNVBGLNYDV-UHFFFAOYSA-N 0.000 description 1
- WVGZZTIINNFUQS-UHFFFAOYSA-O [H+].C[P-](C)(C)(C)(C)C Chemical compound [H+].C[P-](C)(C)(C)(C)C WVGZZTIINNFUQS-UHFFFAOYSA-O 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005257 alkyl acyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial Effects 0.000 description 1
- 230000000843 anti-fungal Effects 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- MEGROZMJHSAQKL-UHFFFAOYSA-N azido(triethyl)silane Chemical compound CC[Si](CC)(CC)N=[N+]=[N-] MEGROZMJHSAQKL-UHFFFAOYSA-N 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M caproate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 150000001731 carboxylic acid azides Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- NISGSNTVMOOSJQ-UHFFFAOYSA-N cyclopentanamine Chemical compound NC1CCCC1 NISGSNTVMOOSJQ-UHFFFAOYSA-N 0.000 description 1
- UCQFCFPECQILOL-UHFFFAOYSA-N diethyl hydrogen phosphate Chemical compound CCOP(O)(=O)OCC UCQFCFPECQILOL-UHFFFAOYSA-N 0.000 description 1
- PDQYDAMNFMHSJS-UHFFFAOYSA-N diethyl propanedioate;sodium Chemical compound [Na].CCOC(=O)CC(=O)OCC PDQYDAMNFMHSJS-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- CHDFNIZLAAFFPX-UHFFFAOYSA-N ethoxyethane;oxolane Chemical compound CCOCC.C1CCOC1 CHDFNIZLAAFFPX-UHFFFAOYSA-N 0.000 description 1
- FFLYUXVZEPLMCL-UHFFFAOYSA-N ethylchloranuidyl formate Chemical compound CC[Cl-]OC=O FFLYUXVZEPLMCL-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 239000008079 hexane Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 229960004251 hydroquinine Drugs 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 108010014374 puros Proteins 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- VYPDUQYOLCLEGS-UHFFFAOYSA-M sodium;2-ethylhexanoate Chemical compound [Na+].CCCCC(CC)C([O-])=O VYPDUQYOLCLEGS-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- JJOWIQMPCCUIGA-UHFFFAOYSA-N trimethyl(morpholin-4-yl)silane Chemical compound C[Si](C)(C)N1CCOCC1 JJOWIQMPCCUIGA-UHFFFAOYSA-N 0.000 description 1
- QVFKXTHXUJSIED-UHFFFAOYSA-N triphenylphosphane;tris(2-methylphenyl)phosphane Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C QVFKXTHXUJSIED-UHFFFAOYSA-N 0.000 description 1
Abstract
New procedure, effective and of high enantiomeric selectivity for the production of enantiomerically pure cyclopentane-α-amino acids. The process according to the invention for the production of enantiomerically pure cyclopentane-α-amino acids of general formula (I), in which A and D have the meanings mentioned in the description, is characterized in that mesodicarboxylic anhydrides are transformed by asymmetric alcoholysis with allyl alcohols and in the presence of a chiral aminated base, present in enantiomerically pure form, in inert solvents first through the enantiomerically pure intermediate salt phase, in the enantiomerically pure monoester of dicarboxylic acid, in another step in the sense of a Curtius transforms this monoester of the dicarboxylic acid by reaction with azides in the corresponding intermediate acid azides and then in the corresponding transposed isocyanates, the isocyanates are then converted with allylic alcohols to the compounds of the general formula (VII) and subsequently They have, by dissociation of the urethane and ester functions, the cyclopentane-α-amino acids of the general formula (
Description
NEW EFFECTIVE AND HIGH SELECTIVITY PROCEDURE ENANTIOMERICA FOR THE PRODUCTION OF CICLOPENTANO-BETA-AMINOACIDOS ENANTIOMERI CAMENTE PUROS
FIELD OF THE INVENTION The present invention relates to an efficient and highly enantiomeric selectivity process for the production of enantiomerically pure cyclopentane-B-amino acids. BACKGROUND OF THE INVENTION For the publications EP 571,800, JP 021 7747 53 A2 and J. Antibiot. (1991), 44 (5), 546-9 cyclopentane-β-amino acids are known. In WO 95/19337 there is described a process for the production of enantiomerically pure cyclopentane- and -penteno-β-amino acids. These are obtained from the corresponding meso-dicarboxylic anhydrides in a synthesis of six stages, with overall yields of 28-40% of the theoretical, with an excess of the enantiomer of > 98%. DESCRIPTION OF THE INVENTION The object of the invention is an efficient and highly enantiomeric selectivity process for the production of enantiomerically pure cyclopentane-B-amino acids of the general formula (I)
wherein A and D are the same or different and represent hydrogen, halogen, hydroxyl or straight or branched alkyl with REF: 24445 to 8 carbon atoms which, if appropriate, is mono- to di-substituted, by the same or different halogen substituents, hydroxyl, phenyl, benzyloxy, carboxy, or by alkoxy, acyl or alkoxycarbonyl, linear or branched, with up to 6 carbon atoms respectively, or by a group of formula -NR7R8, where R7 and R8 are the same or different and mean hydrogen, phenyl or linear or branched alkyl with up to 6 carbon atoms, R1: / A and D together represent a radical of formula C. R2
wherein R1 and R2 are the same or different and mean hydrogen, halogen or alkyl, alkoxy or oxyacyl, linear or branched, with up to 8 carbon atoms, benzyl or phenyl, which is characterized in that meso-dicarboxylic anhydrides of the general formula are transformed (II)
wherein A and D have the meanings indicated above, by an asymmetric alcoholysis with allylic alcohols of general formula (III)
wherein R3, R4 and R5 are the same or different and represent hydrogen or linear or branched alkyl with up to 5 carbon atoms or phenyl which, if appropriate, is trisubstituted by the same or different substituents halogen, cyano, trifluoromethoxy, nitro, trifluoromethyl or by alkyl or alkoxy, linear or branched, with up to 6 carbon atoms respectively, or R3 represents an aromatic heterocycle of 5-7 links with up to 3 heteroatoms of the group S, N and / or O, and in the presence of equimolar amounts of a chiral aminated base, present in enantiomerically pure form, in inert solvents, first through the intermediate enantiomerically pure salt stage of general formula (IV) E © 0 in which A, D, R3, R4 and R5 have the meanings indicated above and E represents the chiral aminated base, in the enantiomerically pure compounds of general formula (IVa)
wherein A, D, R3, R4 and R5 have the meanings indicated above in another step are transformed, in the sense of a Curtius rearrangement, by reaction of the compounds of general formula (IVa) with azides of general formula ( V) (R60) 2-P (0) -N3 (V) in which R6 represents phenyl or linear or branched alkyl with up to 6 carbon atoms, in inert solvents and in the presence of a base, or by activation of the carboxyl group of the compounds of general formula (IVa) and subsequent reaction with alkaline azides or trialkylsilylazides, in the corresponding intermediate acid azides and then in the corresponding transposed isocyanates of the general formula (VI)
wherein A, D, R3, R4 and R5 have the meanings indicated above, isocyanates are then transformed with compounds of general formula (III) into the compounds of general formula (VII)
wherein R3, R4, R5, A and D have the meanings indicated above and then a dissociation of the urethane and ester functions is carried out in inert solvents and in the presence of a Pd and / or a phosphine catalyst and / or of a nucleophilic coadjuvant substance. The process according to the invention can be clarified in an exemplified manner by means of the following scheme of formulas:
In the context of the invention heterocycle represents, in general, an aromatic heterocycle of 5 to 7 links, preferably of 5 to 6 links which can contain up to 3 heteroatoms of the group S, N and / or O. They are to be mentioned by way of example pyridyl, thienyl, furyl, pyrrolyl, thiazolyl, oxazolyl or imidazolyl. Pyridyl and thienyl are preferred. Surprisingly, in the development of the process according to the invention, the chiral compounds of general formula (I) are obtained in an elegant manner with very high enantiomeric purity and, at the same time, with very good yields. In contrast to the state of the art indicated above, the process according to the invention makes possible, from the corresponding isodicarboxylic anhydride, through a Curtius rearrangement, a highly selective enantiomerically pathway for the synthesis of cyclopentane-β- enantiomerically pure amino acids in a shortened synthesis sequence of 6 to 3 stages, with an overall yield of > 45% of theory and an excess of enantiomer of > 99% Another advantage of the process according to the invention is that the volumetric yield in the synthesis of the dicarboxylic monoester (formula IVa) is substantially higher compared to that of the process of the document
WO 95/19337. In addition, the intermediate isolation of the compounds of general formula (IV) is suppressed. Although the compounds of the general formula (IVa) are present with an enantiomer excess of only 80 to 97%, in the next step (Curtius rearrangement), however, in the crystallization of the compounds of the general formula (VI) , an enantiomer excess of > 99% The process according to the invention is further distinguished, as opposed to the state of the art, because the Hofmann rearrangement, introduction and dissociation of a protecting group, are replaced by an efficient Curtius rearrangement. In addition, the dissociation of the urethane and ester functions of the compounds of general formula (VII) is carried out in one step; the product crystallizes in the reaction mixture and, in opposition to the state of the art, can be isolated by a simple filtration. Another advantage of the process according to the invention is that the compounds of general formula (VII), in comparison with the compounds of formula (V) of WO 95/19337, are crystalline and generally crystallize in the reaction mixture. This makes possible a simple manipulation and achieve an enrichment of the enantiomeric purity by crystallization. As the solvent for the conversion of the dicarboxylic anhydrides of the general formula (II), all inert organic solvents which do not change under the reaction conditions are taken into consideration. These preferably include, but are not limited to, ether, ethyl ether, dioxane, diisopropyl ether, t-butyl methyl ether, tetrahydrofuran or glycol dimethyl ether, or hydrocarbons such as toluene, benzene, xylene, hexane, cyclohexane or petroleum fractions, or chlorinated hydrocarbons such as chloroform or ethylene chloride, or amides such as dimethylformamide, di-ethylacetamide or triamide of hexamethylphosphoric acid, or glacial acetic acid, dimethyl sulfoxide, acetonitrile or pyridine. Preferred for the individual steps are diisopropyl ether, diethyl ether, dioxane, t-butyl methyl ether and toluene. The reaction temperatures may vary within a wide range. Generally, it is worked between -602C and + 202C, preferably between -202C and +252C. The transformations can be carried out at normal pressure, but also at elevated or reduced pressure (for example from 0.5 to 80 bar). In general, normal pressure is used. As alcohols for the alcoholysis and for the transformation in the sense of a Curtius rearrangement (formula III), suitable primary allyl alcohols, such as, for example, allyl alcohol or cinnamic alcohol, are suitable. Trans-cinnamic alcohol is especially preferred.
As chiral aminated bases, they are suitable for the process according to the invention, preferably alkaloids and cinchona alkaloids. They are . preferred especially cinchona alkaloids such as, for example (+), (-) - quinine, (+), (-) - hydroquinine, (+), (-) - cinchonidine,
(+), (-) -epiquinidine, (+), (-) -epicinconidine, (+), (-) -cinconine, (+), (-) -epicinconin, (+), (-) -epiquinin, (+),
(-) -hydroquinidine, (+), (-) 4-chlorobenzoate-epiquinine or
(+) t (~) 4-chlorobenzoate-epicinconine. Especially preferred are (+), (-) - quinine and (+), (-) - quinidine. The chiral aminated bases are used in equivalent amounts, based on 1 mole of the dicarboxylic anhydrides of the general formula (II). As acids for the recovery of the free chiral aminated bases are suitable, for example, mineral acids such as hydrochloric acid, hydrobromic acid or sulfuric acid. The acid is generally used in an amount of 1 mol to 10 mol, preferably from 1.5 mol to 4 mol, based on 1 mol of the compounds of general formula (IV). The recovery takes place, in general, in a temperature range from oac to + 502C, preferred from 200C to 30SC and at normal pressure. The transposition of Curtius is carried out, in general, in one of the inert solvents indicated above. Preferred are cyclic hydrocarbons such as benzene, toluene or xylene or ethers such as dioxane or tetrahydrofuran. Toluene is preferred. Suitable amines for the Curtius rearrangement are organic amines such as N-ethylmorpholine, N-methylmorpholine, pyridine, triethylamine or N-methylpiperidine. Triethylamine is preferred. The base is generally used in an amount of 1 mol to 3 mol, preferably 1 mol to 1.5 mol, based on 1 mol of the compounds of the general formula (IVa). As azides of formula (V) for the Curtius rearrangement, phosphoric ester azides are suitable, for example, diphenyl ester azide of phosphoric acid, diethyl ester azide of phosphoric acid. The azide of the diphenyl ester of phosphoric acid is preferred. It is also possible to first convert the carboxylic acid with activating reagents such as (C, -C4) -alkylchloroformates in the presence of an amine, thionyl chloride, phosphorus pentachloride or phosphorus oxychloride, in the corresponding activated derivatives and then obtain , by transformation with alkaline azides, such as sodium azide or trialkylsilylazides, such as tri-ethylsilylazide, the carboxylic acid azides. The Curtius rearrangement is generally carried out in a temperature range from OdC to + 1302C, preferred from 602C to HOSC.
The transposition of Curtius is carried out, in general, at normal pressure. But it is also possible to carry out the process under reduced pressure or at elevated pressure (for example, in a range of 0.5 to 5 bar). Activation of the carboxyl groups of the compounds of the general formula (IVa) is usually carried out with ethyl chloroformate / triethylamine and, in general, in a temperature range of -30 to +252C. The acid azides obtained in this way are then converted by heating a solution in one of the inert solvents indicated above, at temperatures of 60 ° C. to 120 ° C., into the corresponding isocyanates of the general formula (VI). The isocyanates of formula (VI) can be isolated or transformed after their preparation with the alcohols of general formula (III). The dissociation of the urethane and ester functions in the compounds of the general formula (VII) is generally carried out in one of the inert solvents indicated above. Preferred are hydrocarbons such as toluene, benzene or xylene, ethers such as tetrahydrofuran or diethyl ether, esters such as ethyl acetate, alcohols such as ethanol, methanol, isopropanol, acetonitrile or dimethylformamide. Acetonitrile, dimethylformamide, ethyl acetate or ethanol are especially preferred. The dissociation is generally carried out in a temperature range of ose to + 100 ° C, preferred from 202 ° C to 800 ° C.
The dissociation is carried out, in general, at normal pressure. But it is also possible to carry out the process under reduced pressure or at elevated pressure (for example, in a range of 0.5 to 5 bar). Suitable nucleophilic agents for dissociation are, for example, carboxylic acids and their alkali metal salts (for example, formic acid, acetic acid, 2-ethylhexanoic acid, sodium 2-ethylhexanoate), organic amines such as morpholine, triethylamine. , pyrrolidine, dimethyltrimethylsilylamine, trimethylsilylmorpholine, n-butylamine, dimedon, sodium diethylmalonate, tributyltin hydride, N, N-dimethylbarbituric acid or ammonium formate. Morpholine is preferred. The auxiliary agent is generally used in an amount of 1 mol to 20 mol, preferably 1.1 mol to 3 mol, based on 1 mol of the compounds of the general formula (VII). Suitable Pd catalysts are, for example, tetrakistriphenylphosphinpalladium (O) (Pd (PPh3) 4 / PPH3, palladium-dibenzylidenaketone (Pd2 (dba) 3), Pd2 (dba) 3 x, for example, in the process according to the invention. CHC13, Pd (dba) 2, Cl2Pd, (AcO) 2Pd, PdCl2 (PhCN) 2, PdCl2 (CH3CN) 2 or PdCl2 (PPh3) 2. Palladium (II) acetate (AcO) 2Pd is preferred. in general, in an amount of from 0.0001 mol to 0.2 mol, preferably from 0.001 mol to 0.05 mol, based on 1 mol of the compounds of the general formula (VII) As phosphine, they are generally suitable. (C, -C 4) -trialkyl- and triarylphosphines such as triphenylphosphine, triisopropylphosphine or tri-o-tolylphosphine Triphenylphosphine is preferred Compounds of general formula (II) are known or obtainable by published methods. (III), (Illa) and (V) are known The compounds of general formula (VII) are new and can be obtained as described above. preferably, enantiomerically pure compounds of the general formula (I) are obtained, in which A and D are the same or different and represent hydrogen, fluorine or linear or branched alkyl with up to 6 carbon atoms, or R1 / A and D together represent a residue of formula C R2
wherein R1 and R2 are the same or different and denote hydrogen, fluorine, bromine or linear or branched alkyl with up to 6 carbon atoms, benzyl or phenyl. Preferably, enantiomerically pure compounds are obtained by way of the process according to the invention. of general formula (I), in which A and D are the same or different or represent hydrogen or linear or branched alkyl with up to 4 carbon atoms,
R1 'A and D together represent a radical of formula - _C R2 in which R1 and R2 are the same or different and denote hydrogen, linear or branched alkyl with up to
4 carbon atoms The process according to the invention makes it possible to efficiently, elegantly and with high enantiomeric selectivity and at the same time with high yields, access to enantiomerically pure cyclopentane-β-amino acids of general formula (I), which are extremely valuable medications with antifungal and antibacterial action.
Preparation examples Example 1 Ester of 1- (E) -cinnazyl acid (IR, 2S> 4-methylene-cyclopentane-1,2-dicarboxylic acid)
4-Met i len-1,2-cyclopentanedicarboxylic anhydride (90.0 g, 591 mmol) is dissolved in toluene
(2,400 mi), in an atmosphere of N2. At -152C quinine is added
(191.7 g, 591 mmol) and, later, transcinnamic alcohol
(119.2 g, 888 mmol). The reaction mixture is stirred at -15 ° C for at least 4 hours. Allow to warm to room temperature and wash with 1 N HCl (3 x 900 mL) and water (2 x 900 mL). The product is then extracted from the organic phase with 2% aqueous solution of C03K2 (1 x 4.5 1, 2 x 1.5 1). The combined aqueous phases are washed with ethyl acetate (2 x 11), covered with toluene (600 ml) and, under vigorous stirring, adjusted to pH 2 with 10% hydrochloric acid. After separation of the phases, it is extracted twice more with toluene (2 x 600 ml). The combined toluene phases are washed with water (2 x 400 ml) and concentrated in vacuo at 50 ° C./about 20 mbar. Yield: 159.1 g, 94% of theory.
Excess of enantiomer, e.e. > 85% (HPLC, Chiracel OD-H, eluent: n-heptane / isopropanol). If the product is then mixed with toluene (180 ml) and the resulting suspension is stirred for approximately 1 hour after filtration and evaporation of the filtrate in vacuo, the ester of 1- (E) -cinnamyl of the acid is obtained. (IR, 2S) -4-methylenecyclopentane-1,2-dicarboxylic acid (144.6 g, 85% of theory) with an excess of ee enantiomer > 98% (HPLC, Chiracel OD-H, eluent: n-heptane / isopropanol). C17H ,, 04 (286.3):
Theoretical: C 71.31% H 6.34% Found: C 71.27% H 6.42% Example Ester of 1- (E) -cinamyl of (1S, 2R) -4-methylenecyclopentane-1 acid , 2-dicarboxylic
A suspension of quinidine (179.4 g, 553 mmol) is cooled to -152 C under N2 and mixed successively with 4-methylenecyclopentane-1,2-dicarboxylic anhydride (84.0 g, 553 mmol) and transboundary alcohol. cinnamic (111.2 g, 829 mmol).
The reaction mixture is stirred at -15ac for at least 4 hours. The processing is carried out analogously to obtaining the compound of example 1. Yield: 147.3 g, 93% of theory. Excess of enantiomer, e.e. > 93% (HPLC, Chiracel OD-H, eluent: n-heptane / isopropanol). C17Hlg04 (286.3) Theoretical: C 71.31% H 6.34% Found: C 71.23% H 6.32% Example 2 (IR, 2S) -2N- ((E) -cinnaxyloxycarbonyl) amino-4 -metilen-l-cyclo-r pentane-carboxylate of (E) -cinomyl
To the solution of the compound of Example 1 (10.0 g, 34.9 mmol, ee = 85%) in toluene (70 ml) is added successively, dropwise, under a nitrogen atmosphere, triethylamine (3.5 g). , 34.7 mmol) and azide of the phosphoric acid diphenyl ester (9.6 g, 34.9 mraol). The reaction mixture is heated at 90 ° C for about 30 minutes, until nitrogen is no longer evolved. Subsequently, trans-cinnamic alcohol (5.6 g, 41.9 mmol) is added dropwise at 90 ° C. and heated under reflux overnight under nitrogen. Allow the mixture to cool, stirring, to room temperature, continue cooling in a bath with ice to about 3 c, the precipitated product is filtered in vacuo, washed with a total of 50 ml of cold toluene and the product is dried empty at 50ac. Yield: 10.3 g, 70% of theory, white crystals. Excess of enantiomer, e.e. > 99% (HPLC, Chiracel OD-H, eluent: n-heptane / isopropanol + trifluoroacetic acid). P. of f. : 1368C. C26H27N04 (417.51) Theoretical: C 74.80% H 6.52% N 3.36% Found: C 74.88% H 6.44% N 3.51% If the reaction described above is carried out with the compound of Example 1, with an excess of ee enantiomer > 98% under otherwise analogous conditions, then the product is obtained with a yield of 11.7 g (80% of theory), with an excess of > 99% Example 2a (1S, 2R) -2N- ((E) -cinnaxyloxycarbonyl) amino-4-methylene-l-cyclopentane-carboxylate of (E) -cinnamyl
The preparation is analogous to obtaining the compound of Example 2, starting from the compound of example la (30.0 g, 104.8 mmol). Yield: 34.6 g, 79.1% of theory. Excess of enantiomer, e.e. > 99% (HPLC, Chiracel OD-H, eluent: n-heptane / isopropanol + trifluoroacetic acid). C26H27N04 (417.51) Theoretical: C 74.80% H 6.52% N 3.36% Found: C 74.99% H 6.63% N 3.34% Example 3 (IR, 2S) -2N- ((E) -alkyl iloxycarbonyl) -amino-4-methylene-lf cyclopentane-carboxylic acid allyl
The preparation is carried out from the 1-allyl ester of (IR, 2S) -4-methylenecyclopentane-1,2-dicarboxylic acid
(DE 44 007 49 A1, 7.3 g, 34.9 mmol, e.e. = 96%), analogously to that described for example 2. Yield: 7.9 g, 66% of theory, white crystals.
C20H23NO4 (341.38) Theoretical: C 70.36% H 6.79% N 4.10%
Found: C 70.25% H 6.97% N 4.08% Example 4 (-) - (IR, 2S) -2-amino-4-methylene-cyclopentane-1-carboxylic acid
A solution of the compound of Example 2 (180.0 g, 431 mmol) in ethyl acetate (1500 ml) is mixed successively, under N2 with triphenylphosphine
(5.38 g, 20.5 mmol), morpholine (75.1 g, 862 mmol) and palladium (II) acetate (0.97 g, 4.3 mmol). The reaction mixture is heated to reflux for 2 hours and after that it is cooled to about 60ac. The precipitated product is filtered under vacuum, washed with ethyl acetate and dried in vacuo. The crude product is crystallized twice from aqueous ethanol at
85% Yield: 42.6 g, 70% of theory, white crystals. P. of f. : 2223C. [a] 20D = 31.6 (c = 1, H20). C7HpN02 (141.2) Theoretical: C 59.56% H 7.85% N 9.92%
Found: C 59.46% H 7.85% N 9.88% Analogously and with almost the same yields the production of the compound of Example 4 is obtained from the compound of Example 3. Example 4a Acid (+) - (1S , 2R) -2-amino-4-methylene-cyclopentane-1-carboxylic acid
H2N CO,
The preparation is analogous to obtaining the compound of Example 4, starting from the compound of the example
2a (60.3 g, 144.4 mmol). Yield: 12.4 g, 67.6% of theory. P. of f .: 233ac (decomp.). [a] 20D = +32.2 (c = l, 02, H20). Theoretical: C 59.56% H 7.85% N 9.92%
Found: C 59.09% H 7.74% N 9.87%
Example 5 Ester of 1- (E) -cinomyl of (IR, 2S) -cyclopentane-1,2-dicarboxylic acid
A suspension of quinine (50.9 g, 157.1 mmol) in toluene (634 ml) is mixed successively, at -15ac under N2, with cyclopentane-1,2-dicarboxylic anhydride (22.0 g, 157.1 mmol) and trans-cinnamic alcohol (31.6 g, 235.7 mmol). The reaction mixture is stirred at
-15ac for at least 4 hours. Allow to warm to room temperature and wash with 1 N HCl (2 x 240 mL) and water (240 mL). The product is then extracted from the organic phase with 2.2% aqueous solution of C03K2 (1 x 1210 ml, 1 x 400 ml). The combined aqueous phases are washed with ethyl acetate (2 x 260 ml), covered with toluene (260 ml) and, under vigorous stirring, adjusted to pH 2 with 10% hydrochloric acid. After separation of the phases, it is extracted once more with toluene (260 ml). The combined toluene phases are washed with water (2 x 130 ml) and concentrated in vacuo at 50 ° C. Yield: 40.2 g, (93% of theory). Excess of enantiomer, e.e. > 86% (HPLC). C16H1804 (274.3) Theoretical: C 70.06% H 6.61% Found: C 69.66% H 6.42% Example 6 (IR, 2S) -2N- ((E) -cinnaxyloxycarbonyl) amino-cyclopentane -1- (E) -cinamyl carboxylate
To the solution of the compound of Example 5 (39.3 g, 143 mmol) in toluene (286 ml) is added successively, dropwise, under N2, triethylamine (14.3 g, 142 mmol) and sodium azide. Phosphoric acid diphenyl ester (39.4 g, 143 mmol). The reaction mixture is heated at 90 ° C for about 30 minutes and then trans-cinnamic alcohol (23.0 g, 172 mmol) is added dropwise at this temperature and the mixture is refluxed overnight. The mixture is allowed to cool, with stirring, to 30 ° C., the precipitated crude product (14.2 g) is filtered in vacuo and then washed with cold toluene (60 ml). The mother liquors are washed successively with 5% aqueous solution of citric acid (410 ml), water (410 ml), saturated NaCl solution (410 ml) and saturated NaCl solution (410 ml). After concentrating the organic phase in vacuo, more crude product is obtained (30.0 g). The crude product is then crystallized from isopropanol. Yield: 33.3 g (57.3% of theory), white crystals. Excess of enantiomer, e.e. > 99% (HPLC, Chiracel OD-H).
P. of f. : 84-858C. C25H27N04 (405, 5) Theoretical: C 74.05% H 6.71% N 3.45%
Found: C 74.12% H 6.58% N 3.53% Example 7 (-) - (IR, 2S) -2-amino-cyclopentane-1-carboxylic acid A solution of the compound of Example 6 (44.8 g, 110.5 mmol) and triphenylphosphine (1.37 g, 5.2 mmol) in ethanol (127 ml), mixed under N2 with morpholine (19.3 g, 221 mmol) and palladium acetate (II ) (0.062 g, 0.28 mmol). The reaction mixture is refluxed for 2 hours, mixed with 3-mercapto-l, 2,4-triazole (1.12 g, 11.1 mmol), heated to reflux for an additional 1.5 hours and then from this it cools to 0-5ac. The precipitated crude product is filtered under vacuum, washed with ethanol and dried in vacuo. The crude product is crystallized from 85% aqueous ethanol, in the presence of 5% molar mercapto-1, 2,4-triazole. Yield: 9.4 g (66% of theory), white crystals. P. de f .: 218ac (decomp.). [a] 20D = 9.9 (c = 1, 0, H20). Theoretical: C 55.80% H 8.59% N 10.84% Found: C 55.53% H 8.24% N 10.83% It is noted that, in relation to this date, the best method known by The applicant for carrying out the said invention is the one that is clear from the present description of the invention.
Having described the invention as above, property is claimed as contained in the following:
Claims (1)
1. SUMMARY OF THE INVENTION New, efficient and highly enantiomeric selectivity procedure for the production of enantiomerically pure cyclopentane-β-amino acids. The process according to the invention for the production of enantiomerically pure cyclopentane-β-amino acids, of general formula (I) wherein A and D have the meanings mentioned in the description is characterized in that isodicarboxylic anhydrides are transformed by asymmetric alcoholysis - with allylic alcohols and in the presence of a chiral aminated base, present in enantiomerically pure form, in inert solvents first through of the enantiomerically pure salt intermediate stage in the enantiomerically pure monoester of dicarboxylic acid, in another step in the sense of a Curtius rearrangement, this monoester of the dicarboxylic acid is converted by reaction with azides into the corresponding intermediate acid azides and then in the corresponding transposed isocyanates, the isocyanates are then converted with allylic alcohols to the compounds of general formula (VII) and then the cyclopentane-β-amino acids of general formula (I) are obtained by cleavage of the urethane and ester functions. .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19617772A DE19617772A1 (en) | 1996-05-03 | 1996-05-03 | New efficient and highly enantioselective process for the production of enantiomerically pure cyclopentane-beta-amino acids |
DE19617772.3 | 1996-05-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9702768A MX9702768A (en) | 1997-11-29 |
MXPA97002768A true MXPA97002768A (en) | 1998-07-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101821090B1 (en) | Process for manufacture of n-acylbiphenyl alanine | |
JP2003513974A (en) | Method for producing imidazolidinone αv-integrin antagonist and intermediate for production | |
US5962724A (en) | High enantio-selective process for producing pure enantiomeric cyclopentane and cyclopentene-(β)-amino acids | |
US6548665B2 (en) | Asymmetric synthesis of a key intermediate for making benazepril and analogues thereof | |
KR101150558B1 (en) | Process for preparing oxcarbazepine | |
KR100649175B1 (en) | Method for producing enantiomer-free n-methyl-n-[1s-1-phenyl-2-3s-3-hydroxypyrrolidine-1-ylethyl]-2,2-diphenyl acetamide | |
MXPA97002768A (en) | New effective and high selectivity procedureanantiomerica for the production of ciclopentano-beta- aminoacidos enantiomericamente pu | |
US6031103A (en) | Process for manufacturing 1-[3-cyclopentyl -2(R)-[1(R)-hydroxycarbamoyl)-2-(3, 4, 4-trimethyl -2, 5-D ioxo-1-imidazolidinyl) ethyl] propionyl] piperidine | |
US5877343A (en) | Efficient and highly enantioselective process for the preparation of enantiomerically pure cyclopentane-β-amino acids | |
JP2001521498A (en) | Method for producing O- (3-amino-2-hydroxy-propyl) -hydroxymic acid halide | |
KR20020019895A (en) | Process for preparing [S-(R*,R*)-β-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives | |
AU647562B2 (en) | Process and intermediate for certain bis-aza-bicyclic anxiolytic agents | |
US6531624B1 (en) | Aminoacrylic acid derivatives and process for producing the same | |
IL174189A (en) | Process for preparing 1,8-naphthyridine-3-carboxylic acid compounds | |
CN113773323B (en) | Preparation method of 3R-amino substituted butyramide derivative | |
KR100869165B1 (en) | Process for preparing meropenem | |
MXPA02004873A (en) | Method for production of benzofuranone oximes. | |
KR100192123B1 (en) | Novel process for preparing bicyclic amines | |
JPH04270272A (en) | Production of aminoalkylmorpholine derivative | |
US6300503B1 (en) | Hydantoin intermediates for the synthesis of omapatrilat and methods for producing and using the same | |
US5294714A (en) | 2,5-dioxopiperazine compounds and method for preparing α-aspartyl-L-phenylalanine methyl ester derivatives | |
US20020042523A1 (en) | Process for producing 1H-3-aminopyrrolidine and derivatives thereof | |
CN117843613A (en) | Preparation method of dabigatran etexilate intermediate | |
IL139642A (en) | Lower alkanesulphonate salts of cyanobenzylamines and processes for their production | |
JPH0446175A (en) | Production of 5-hydroxy-3,4-methylenedioxybenzoic acid derivative |